An Open-label, Multi-center Phase Ⅳ Trial to Evaluate the Efficacy and Safety of Sequential Neoadjuvant Chemotherapy With Docetaxel(Monotaxel®) After Doxorubicin Plus Cyclophosphamide Combination Chemotherapy in Locally Advanced Breast Cancer

NCT01660542 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
96
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Yonsei University